News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Puissance Life Science Opportunities Fund VI
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/07/2023 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Sold 134,421 shares
@ $0.83, valued at
$111.6k
|
|
| 05/19/2023 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Sold 560,000 shares
@ $9.46, valued at
$5.3M
|
|
| 06/08/2021 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 8,189 shares
@ $4, valued at
$32.8k
|
|
| 04/26/2021 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 609,231 shares
@ $4, valued at
$2.4M
Granted 380,950 warrants
@ $12, valued at
$4.6M
Granted 304,286 warrants
@ $18.63, valued at
$5.7M
|
|
| 05/22/2020 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 1,153,846 shares
@ $13, valued at
$15M
|
|
| 12/03/2018 |
4
| Puissance Cross-Border Opportunities V LLC (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 4,326 shares
@ $1.13, valued at
$4.9k
Sold 4,326 shares
@ $1.21, valued at
$5.2k
|
|
|
|